Navigation Links
Shedding new light on one of diabetes' most dangerous complications
Date:8/30/2012

WASHINGTON, Aug. 30, 2012For many diabetics, monitoring their condition involves much more than adhering to a routine of glucose sensing and insulin injections. It also entails carefully monitoring the ongoing toll this disease takes on their body.

An innovative new optical diagnostic tool created by Columbia University researchers and reported today in the Optical Society's (OSA) open-access journal Biomedical Optics Express may soon make it easier to diagnose and monitor one of the most serious complications of diabetes, peripheral arterial disease (PAD). PAD, which is marked by a narrowing of the arteries caused by plaque accumulation, frequently results in insufficient blood flow to the body's extremities and increases a person's risk for heart attack and stroke.

This new noninvasive imaging technique known as dynamic diffuse optical tomography imaging (DDOT) uses near-infrared light to map the concentration of hemoglobin in the body's tissue. This mapping can reveal how effectively blood is flowing to patients' hands and feet.

"Currently, there are no good methods to assess and monitor PAD in diabetic patients," explains Andreas Hielscher, Ph.D., professor of Biomedical and Electrical Engineering and Radiology, and director of the Biophotonics and Optical Radiology Laboratory at Columbia University.

"Patients with PAD experience foot pain, called 'claudication,' while walking," adds Gautam Shrikhande, M.D., assistant professor of surgery, and director of the Vascular Laboratory at Columbia's Medical Center. "This pain continues, even at rest, as the disease progresses. In more advanced stages, PAD patients develop sores or ulcers that won't heal. Then, cell death, a.k.a. 'gangrene,' occurs and amputation is often the only solution. It's extremely important to diagnose PAD early, because medication and lifestyle changes can alleviate the disease."

This is where DDOT can help. "We've successfully used DDOT to detect PAD in the lower extremities," says Michael Khalil, a Ph.D. candidate working with Hielscher at Columbia. "One key reason why DDOT shows so much promise as a diagnostic and monitoring tool is that, unlike other methods, it can provide maps of oxy, deoxy and total hemoglobin concentration throughout the foot and identify problematic regions that require intervention."

"Using instrumentation for fast image acquisition lets us observe blood volume over time in response to stimulus such as a pressure cuff occlusion or blockage," said Hielscher.

To map and monitor the presence of hemoglobin, the protein that carries oxygen in the blood, red and near-infrared light is shone at different angles around areas that are susceptible to arterial disease. These specific wavelengths of light are then absorbed or scattered, depending on the concentration of hemoglobin.

"In the case of tissue, light is absorbed by hemoglobin. Since hemoglobin is the main protein in blood, we can image blood concentrations within the foot without using a contrast agent," Hielscher points out. Contrast agents pose the risk of renal failure in some cases, so the ability to monitor PAD without using a contrast agent is a great advantage.

Since more than 25 million people or 8 percent of the population in the United States are diabetic, this diagnostic tool has the potential to make it significantly simpler to diagnose and monitor diabetics with PAD in the future.

Khalil, Hielscher, and colleagues hope to bring their diagnostic tool to market and into clinics within the next 3 years.


'/>"/>

Contact: Angela Stark
astark@osa.org
202-416-1443
Optical Society of America
Source:Eurekalert  

Related biology news :

1. Notre Dame researcher is shedding light on how jaws evolve
2. Fast food restaurant lighting and music can reduce calorie intake and increase satisfaction
3. Biomass characterization technology research highlighted in Industrial Biotechnology journal
4. Athletic field paint steals spotlight from the grass it covers
5. Research on wood formation sheds light on plant biology
6. Origami inspires research into materials that self-assemble when exposed to light
7. Team receives $22.5 million to shed light on the immune system
8. Imaging study sheds new light on alcohol-related birth defects
9. Scientists shed light on glowing materials
10. Studies shed light on why species stay or go in response to climate change
11. Scientists use light to tag and track genetic processes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Shedding new light on one of diabetes' most dangerous complications
(Date:5/16/2016)...   EyeLock LLC , a market leader of ... an IoT Center of Excellence in Austin, ... of embedded iris biometric applications. EyeLock,s iris ... security with unmatched biometric accuracy, making it the most ... EyeLock,s platform uses video technology to deliver a fast ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® ... provides a free webinar on Performing Quality Investigations: Getting to Root ... CT at no charge. , Incomplete investigations are still a major concern to ...
(Date:6/23/2016)... June 22, 2016  Amgen (NASDAQ: AMGN ... QB3@953 life sciences incubator to accelerate the ... shared laboratory space at QB3@953 was created to help ... obstacle for many early stage organizations - access to ... sponsorship, Amgen launched two "Amgen Golden Ticket" awards, providing ...
(Date:6/22/2016)... Cell Applications, Inc. and StemoniX announced ... up to one billion human induced pluripotent stem ... These high-quality, consistent stem cells enable researchers to ... more time doing meaningful, relevant research. This achievement ... process that produces affordable, reliable HiPSC for life ...
Breaking Biology Technology: